Received Feb 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLUC4 | INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT) | SEQIRUS, INC. | 4 | 946595 | IM / LA |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | X026926 | IM / RA |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 2 | Y008284 | SC / RA |
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | LN75D | IM / LA |
On October 1, 2024 PH received a shipment of COVID vaccine that needed to be stored in the freezer. There was no room in the freezer to accomodate the shipment. The following document was found on the FDA website It was assumed that ProQuad could be stored in both the freezer and refrigerator and both State and Private ProQuad were moved to the refrigerators where they remained within normal refrigerated temperature range until administration. The dose of MMRV administered to this client was one that was removed from the freezer to the refrigerator on October 1, 2024.